KRISZTINA EMODI: Open Payments
NPI 1831573633 · SAN FRANCISCO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$920 in 14 payments from 5 companies in 2025. Trend: 2023 $30 · 2024 $62 · 2025 $920
Food & beverage: $835Education: $85
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 9 | $629 |
| COLOPLAST CORP | 1 | $177 |
| AngioDynamics, Inc. | 2 | $52 |
| PFIZER INC. | 1 | $45 |
| Ferring Pharmaceuticals Inc. | 1 | $17 |
Products named: ERLEADA, RYBREVANT, SenSura Mio, NANOKNIFE, XTANDI, ADSTILADRIN.
Industry payments across CA — which companies pay providers there.
